Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CVRx (CVRX) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for CVRx (CVRX) over the last 6 years, with Q4 2025 value amounting to $75.7 million.

  • CVRx's Cash & Equivalents fell 2853.22% to $75.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $75.7 million, marking a year-over-year decrease of 2853.22%. This contributed to the annual value of $75.7 million for FY2025, which is 2853.22% down from last year.
  • As of Q4 2025, CVRx's Cash & Equivalents stood at $75.7 million, which was down 2853.22% from $85.1 million recorded in Q3 2025.
  • CVRx's Cash & Equivalents' 5-year high stood at $170.9 million during Q3 2021, with a 5-year trough of $47.1 million in Q2 2021.
  • For the 5-year period, CVRx's Cash & Equivalents averaged around $100.6 million, with its median value being $100.2 million (2024).
  • Within the past 5 years, the most significant YoY rise in CVRx's Cash & Equivalents was 15748.18% (2022), while the steepest drop was 3564.85% (2022).
  • Over the past 5 years, CVRx's Cash & Equivalents (Quarter) stood at $142.1 million in 2021, then decreased by 25.25% to $106.2 million in 2022, then fell by 14.71% to $90.6 million in 2023, then grew by 16.96% to $105.9 million in 2024, then decreased by 28.53% to $75.7 million in 2025.
  • Its Cash & Equivalents stands at $75.7 million for Q4 2025, versus $85.1 million for Q3 2025 and $95.0 million for Q2 2025.